Vaxxit, the only Italian startup, participates in the final of the China Overseas Talents Innovation and Entrepreneurship Competition

The final of the “China Overseas Talents Innovation and Entrepreneurship Competition” was held online and offline in Wuhan on October 12 following the previous stage of the competition which took place on July 31.

This is an annual event of the CAST (China Association of Science and Technology) co-organized by ITTN (International Technology Transfer Network) in collaboration with SPICI. It was established to showcase significant international high-tech projects that stand out for their originality and creativity and to attract top-level foreign talents to Wuhan.

83 projects were presented at this year’s final competition and were divided into 3 thematic areas:

• Big Health

• Electronic Information Technology

• Advanced Manufacturing & New Materials

The Italian biopharmaceutical startup Vaxxit was the only Italian company selected for the final competition in the Big Health category. Giovanni Cozzone, CEO of Vaxxit, presented the vaccines developed by the company against HIV, Herpes Simplex Virus (HSV), and M. Tuberculosis (TB).

After many years of international collaborations in research and commercialization, Vaxxit is currently seeking partnerships with members of the Chinese innovation ecosystem.